Hartford News Today | 2 Min News | The Daily News Now!

Insurity Invests $100M in AI for Insurance | Hartford News

2 min · 27 de jul de 2026
Portada del episodio Insurity Invests $100M in AI for Insurance | Hartford News

Descripción

Insurity is pouring $100 million into AI over the next two years to modernize insurance operations, reduce costs, and simplify the customer experience — a bold move led by new CEO Jatin Atre. Building on a prior $50 million AI investment, the company plans to embed AI into its own systems while developing new tools for its 500+ carrier clients. With the insurance industry’s heavy regulation, Insurity positions itself as a trusted partner to help firms adopt AI responsibly and transparently. As McKinsey confirms, AI adoption is accelerating across the sector, though most insurers are still in early stages — Insurity’s big bet signals it’s ready to lead the charge in reshaping insurance with smarter, scalable technology. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/73efbcc854509c90

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Hartford News Today | 2 Min News | The Daily News Now!!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

300 episodios

Portada del episodio Jury Awards $4M for Stolen Protein Tech | Hartford News

Jury Awards $4M for Stolen Protein Tech | Hartford News

A federal jury just awarded Yale and Biohaven a whopping $4 million after finding RA Capital and Avilar Therapeutics willfully stole Yale’s proprietary protein degradation tech, MODA. The case, filed in March 2023, centered on confidential data RA Capital accessed in 2019 during a failed deal — data allegedly used to launch Avilar, a rival company. The jury sided with plaintiffs, ruling RA Capital breached confidentiality and misappropriated key trade secrets worth $2 million each, totaling $4 million. RA Capital called the verdict “modest” and denied wrongdoing, while Biohaven and Yale hailed the win as a victory for innovation and integrity in biotech partnerships. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/2aeceb385d417d5f

27 de jul de 20262 min